Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer.
Autor: | Danson, S.1, Ferry, D.2, Alakhov, V.3, Margison, J.1, Kerr, D.2, Jowle, D.1, Brampton, M.4, Halbert, G.5, Ranson, M.1 malcolm.ranson@man.ac.uk |
---|---|
Zdroj: | British Journal of Cancer. 6/1/2004, Vol. 90 Issue 11, p2085-2091. 7p. |
Databáze: | Academic Search Ultimate |
Externí odkaz: |